Fig. 2From: Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivationA. Lymphocyte counts of the two groups (B). D-dimer levels of the two groups (C). Hospital costs of the two groups (D). Hospital lengths of stay of the two groupsBack to article page